Irbesartan for the treatment of hypertension in patients with the metabolic syndrome: A sub analysis of the Treat to Target post authorization survey. Prospective observational, tw...

por Kintscher, Ulrich, Bramlage, Peter, Paar, W Dieter, Thoenes, Martin, Unger, Thomas
Publicado 2007

PEARL: A Non-interventional Study of Real-World Alirocumab Use in German Clinical Practice

por Parhofer, Klaus G., von Stritzky, Berndt, Pietschmann, Nicole, Dorn, Cornelia, Paar, W. Dieter
Publicado 2019

Hypercholesterolemia Diagnosis, Treatment Patterns, and 12-Month Target Achievement in Clinical Practice in Germany in Patients with Familial Hypercholesterolemia

por Gitt, Anselm K., Laufs, Ulrich, März, Winfried, Paar, W. Dieter, Bramlage, Peter, Marx, Nikolaus, Parhofer, Klaus G.
Publicado 2022

Intensified lipid-lowering treatment with alirocumab in patients with coronary heart disease

por Steffens, Daniel, Bramlage, Peter, Müller, Julia, Dorn, Cornelia, Paar, W Dieter, Scheeff, Celine, Kasner, Mario, Rauch-Kröhnert, U
Publicado 2021

First-line antihypertensive treatment in patients with pre-diabetes: Rationale, design and baseline results of the ADaPT investigation

por Zidek, Walter, Schrader, Joachim, Lüders, Stephan, Matthaei, Stephan, Hasslacher, Christoph, Hoyer, Joachim, Bramlage, Peter, Sturm, Claus-Dieter, Paar, W Dieter
Publicado 2008

Ramipril-based versus diuretic-based antihypertensive primary treatment in patients with pre-diabetes (ADaPT) study

por Zidek, Walter, Schrader, Joachim, Lüders, Stephan, Matthaei, Stephan, Hasslacher, Christoph, Hoyer, Joachim, Zemmrich, Claudia, Bramlage, Peter, Sturm, Claus-Dieter, Paar, W Dieter
Publicado 2012